JAK2-IN-13
Product Specifications
Target
STAT, JAK
Related Pathways
Stem Cells, Tyrosine Kinase/Adaptors, Chromatin/Epigenetic, JAK/STAT signaling, Angiogenesis
Bioactivity
JAK2-IN-13 is a potent and orally active JAK2 inhibitor with an IC50 of 54.7 nM. It downregulates the expression of p-STAT3 and p-STAT5 and exhibits good bioavailability. JAK2-IN-13 effectively suppresses recombinant human erythropoietin-induced extramedullary erythropoiesis as well as polycythemia vera. It is used in the study of myeloproliferative neoplasms.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6186678-01 0.1 mL
FOXM1 (Forkhead Box M1, FKHL16, FOXM1B, HFH-11, HFH11, HNF-3, INS-1, MPHOSPH2, MPP-2, MPP2, PIG29, TGT3, TRIDENT) (PE)
Sign In for Pricing
View Details MBS6186678-02 5x 0.1 mL
FOXM1 (Forkhead Box M1, FKHL16, FOXM1B, HFH-11, HFH11, HNF-3, INS-1, MPHOSPH2, MPP-2, MPP2, PIG29, TGT3, TRIDENT) (PE)
Sign In for Pricing
View Details MBS1245036-01 0.02 mg (E-Coli)
Recombinant Klebsiella pneumoniae Urease accessory protein UreF (ureF)
Sign In for Pricing
View Details MBS1245036-02 0.1 mg (E-Coli)
Recombinant Klebsiella pneumoniae Urease accessory protein UreF (ureF)
Sign In for Pricing
View Details MBS1245036-03 0.02 mg (Yeast)
Recombinant Klebsiella pneumoniae Urease accessory protein UreF (ureF)
Sign In for Pricing
View Details